The Department of Health and Human Services on Oct. 28 hosted a briefing on best practices for IV fluid conservation. The briefing included insights from HHS as well as health systems and group purchasing organizations.
This comes after the Centers for Disease Control and Prevention issued an Oct. 12 health advisory on a supply disruption of peritoneal dialysis and IV solutions from the Baxter International’s North Cove facility in North Carolina, due to Hurricane Helene. The health advisory summarizes recommendations and resources for health care providers impacted by the supply disruption.
FDA Extends Use Dates for Baxter Products
The Food and Drug Administration on Oct. 28 extended use dates for select Baxter parenteral drug products. Providers and patients that have specific lot numbers in stock may use them through the corresponding new use dates to help ease supply disruption.
If you are experiencing severe supply shortages, contact Director of Policy Rob Nelb, MPH, at rnelb@essentialhospitals.org or 202.585.0127. He may be able to connect you directly with Baxter leadership.
Author